Non disponible en dehors du Royaume-Uni et de l'Irlande
Biochem/physiol Actions
5-HT1A serotonin receptor agonist; anxiolytic.
Features and Benefits
This compound was developed by Bristol-Myers Squibb. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
Ce produit répond aux critères suivants: